ResearcherSoochow UniversityNo recent work listed

Ye Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2111-7729; OpenAlex author ID A5046933779. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. Last author DOI 10.1007/s10735-022-10076-8 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cheng Hang · 1 shared paper, 2022 · strength 0.15
- Paper β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 … DOI 10.1007/s10735-022-10076-8 ↗
Jianxin Zhu · 1 shared paper, 2022 · strength 0.15
- Paper β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 … DOI 10.1007/s10735-022-10076-8 ↗
Gong Chen · 1 shared paper, 2022 · strength 0.15
- Paper β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 … DOI 10.1007/s10735-022-10076-8 ↗
Haifeng Chen · 1 shared paper, 2022 · strength 0.15
- Paper β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 … DOI 10.1007/s10735-022-10076-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.